Politics & Policy
EXCLUSIVE: Trump’s former FDA nominee vowed new abortion pill safety review after pressure from Sen Hawley
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.
Read more at FOX ›
Read the full story at
FOX
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX, and the link opens their page. This page exists so readers can find, share, and discuss the story here.